Navigation Links
K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P
Date:10/13/2011

and uncertainties. In connection with the PSLRA's "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, competitive, political, regulatory and technological factors, among others, that could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following:

  1. our ability to continue as a going concern;
  2. the impact of competitive, commercial payor, governmental (including Medicaid program), physician, patient, public or political responses and reactions, and responses and reactions by medical professional associations and advocacy groups, to the Company's sales, marketing, product pricing, product access and strategic efforts with respect to Makena™, and its other products, including introduction or potential introduction of generic or competing products, or competition from unapproved therapies or compounded drugs, against products sold by the Company and its subsidiaries, including Makena™, and including competitive or responsive pricing changes;
  3. the possibility of not obtaining the U.S. Food and Drug Administration (the "FDA") approvals or delay in obtaining FDA approvals;
  4. the impact of: (i) the FDA's decision to decline to take enforcement action with regards to compounded alternatives to the Company's Makena ™ product despite the Company's orphan drug exclusivity; (ii) CMS policy permitting Medicaid program reimbursement of such products; and (iii) resulting coverage decisions by various state Medicaid and commercial payors, on the Company's sales revenues for Makena ™ and the resulting impact on the Company's operations and financial results, including, without limitation, its ability to continue as a going concern;
  5. new product development and launch, includ
    '/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
2. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
3. Amylin Pharmaceuticals to Webcast Third Quarter Results
4. Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
5. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
6. Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA)
7. Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011
8. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
9. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
10. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
11. Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2011 CPhI Frankfurt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... SAN DIEGO , March 27, 2015 /PRNewswire/ ... informatics company, today announced new data showing that, ... Mantis TM technology provided highly equivalent interpretations ... cause disease, and did so in a fraction ... pave the way for more comprehensive genetic analysis ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
Breaking Medicine Technology:New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... Md., Dec. 13, 2011 Vanda Pharmaceuticals Inc. (Vanda) ... on the development and commercialization of products for central ... with Megapharm Ltd., one of Israel,s leading private biotech, ... of Fanapt™  in Israel. "We are excited ...
... VIEW, Calif., Dec. 13, 2011 Alexza Pharmaceuticals, Inc. ... Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food ... (Staccato® loxapine) be approved for use as a single ... recommended Risk Evaluation and Mitigation Strategy (REMS), for the ...
Cached Medicine Technology:Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 4FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 2FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 3FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 4FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 5
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes of ... time, key information for understanding and treating this intractable ... story on the Surviving Mesothelioma website. , ... British Columbia Cancer Agency, and PhenoPath lab in Seattle, ... and mutations that can lead to peritoneal mesothelioma ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
(Date:3/28/2015)... Purity Products®, a leading direct ... release of their revolutionary new weight loss product, ... double-blind, placebo-controlled clinical studies to be effective in ... MuffinStop™ is a combination of two traditionally used ... together to create one of the most innovative ...
(Date:3/27/2015)... March 27, 2015 Wellness for Cancer–the ... business criteria for the spa and wellness industry–has certified ... who have experienced or are living with cancer. ... Wellness 365® Network, will be identified with a special ... a provider of safe, therapeutic services for cancer patients. ...
(Date:3/27/2015)... First Choice Emergency Room opened its new Summerwood ... W Lake Houston Pkwy, Houston, Texas and is open 24-7. ... to delivering the highest quality emergency medical care to my ... Choice Emergency Room Summerwood. , To celebrate the ... Creek High School at First Choice Emergency Room’s ribbon cutting ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... Kate Weber, registered dietician, certified personal trainer, marathoner, and wellness enthusiast ... to live a better, longer, healthier and younger ... ... Dec. 17 be, better nutrition for active,lifestyles available exclusively at ...
... BC, Dec. 17 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals,Corporation (NASDAQ: ... Aspreva,s,shareholders and optionholders have approved the proposed acquisition ... wholly-owned Canadian,subsidiary, at a price of US$26.00 per ... held this morning, the transaction was approved,by over ...
... U.S. hospitals , , MONDAY, Dec. 17 (HealthDay News) -- ... pain and anxiety that often follows major surgery, new ... response was equivalent to a [dose] of morphine, which ... B. Hinshaw, professor of surgery and a member of ...
... with their teeth than professionals might think, survey finds , , ... much happier with the condition of their teeth and smiles ... view eyes and teeth as the most important aspects of ... ease with the appearance of their teeth, the study found. ...
... Aim to Facilitate the Training of Interventional Cardiologists ... Treat Growing Population of Cardiovascular Patients, ... launched today by the,Society for Cardiovascular Angiography and ... fund approved training positions,thereby expanding the number of ...
... CSG/SportsCoatings,today announced a major deal that ... FabricAide(TM), to 25 high schools in,Virginia,s Fairfax ... District is the model for how schools ... towards minimizing prevalent,bacterial issues like staph and ...
Cached Medicine News:Health News:be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 3Health News:Aspreva obtains shareholder approval for acquisition by Galenica 4Health News:Massage Eases Pain, Anxiety After Surgery 2Health News:Dentists Take Dimmer View of Patients' Smiles 2Health News:Dentists Take Dimmer View of Patients' Smiles 3Health News:Dentists Take Dimmer View of Patients' Smiles 4Health News:SCAI Announces New Program to Support Interventional Cardiology Training Fellowships 2Health News:SCAI Announces New Program to Support Interventional Cardiology Training Fellowships 3Health News:Virginia School District Gets Proactive Against MRSA 2
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: